Gestational Weight Gain Influences the Adipokine-Oxidative Stress Association during Pregnancy

Juan Mario Solis Paredes1, Otilia Perichart Perera2, Araceli Montoya Estrada3

  • 1Department of Human Genetics and Genomics, Instituto Nacional de Perinatologia, Mexico City, Mexico.

Obesity Facts
|September 18, 2021
PubMed

Insights

Excessive gestational weight gain in pregnancy is linked to altered adipokine levels and increased oxidative stress markers. These changes in adipokines and oxidative stress are associated with abnormal adipose tissue accumulation during pregnancy.

Area of Science:

  • Reproductive biology
  • Metabolic health
  • Biochemistry

Background:

  • Gestational weight gain (GWG) significantly impacts maternal and infant health.
  • Excessive GWG is associated with adverse outcomes like gestational diabetes and future obesity.
  • Adipose tissue dysfunction and oxidative stress are implicated in abnormal GWG.

Purpose of the Study:

  • To investigate the relationship between adipokines and oxidative stress markers in pregnant women.
  • To determine how gestational weight gain influences these associations.

Main Methods:

  • Maternal serum samples were collected in the third trimester (n=74).
  • Assayed adipokines (adiponectin, leptin, resistin) and oxidative stress markers (8-oxodG, LOOH, MDA, CP).
  • Measured glucose as a metabolic marker.

Main Results:

  • Women with excessive GWG had lower adiponectin levels.
  • Adiponectin correlated with 8-oxodG in adequate/insufficient GWG groups, but not in excessive GWG.
  • Leptin was positively associated with oxidative markers (LOOH, MDA, CP) in excessive GWG.

Conclusions:

  • Adipokine production and oxidative stress are concurrently regulated in pregnancy.
  • Gestational weight gain, particularly excessive gain, influences this regulation.
  • Excessive adipose tissue accumulation likely plays a role in these altered associations.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
721
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
24
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
28
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
91